tiprankstipranks
Advertisement

IWM - ETF AI Analysis

Compare

Top Page

IWM

iShares Russell 2000 ETF (IWM)

Rating:62Neutral
Price Target:
IWM, the iShares Russell 2000 ETF, has a solid overall rating driven by several strong holdings with healthy financial performance and growth prospects, such as Krystal Biotech, Old National Bancorp, CareTrust REIT, and UMB Financial, which benefit from robust earnings, strategic expansion, and supportive technical trends. The fund also includes more mixed names like Cytokinetics and ViaSat, where financial and regulatory challenges and profitability issues add some risk. A key risk factor for IWM is its exposure to smaller companies with higher leverage, valuation concerns, and occasional overbought technical conditions, which can make the ETF more volatile.
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, indicating solid recent momentum in its small-cap holdings.
Broad Sector Diversification
Holdings spread across many sectors, including health care, financials, technology, and industrials, help reduce the impact of weakness in any single industry.
Low Expense Ratio for a Small-Cap Fund
The fund’s relatively low ongoing fee means more of the returns from its small-cap stocks can stay in investors’ pockets.
Negative Factors
Heavy U.S. Concentration
With almost all assets in U.S. companies, the ETF offers limited geographic diversification and is highly tied to the U.S. economy.
Short-Term Performance Bumps
The ETF has seen a recent dip over the past month, showing that returns can be choppy over shorter time periods.
Top Holdings in Volatile Areas
Several leading positions are in smaller, more volatile companies that can experience sharp price swings, increasing overall risk.

IWM vs. SPDR S&P 500 ETF (SPY)

IWM Summary

The iShares Russell 2000 ETF (IWM) is a fund that tracks the Russell 2000 Index, which is made up of 2,000 smaller U.S. companies. These are mainly U.S.-based businesses across many sectors like health care, financials, technology, and industrials. Examples of companies in the fund include BrightSpring Health Services and Moog. Someone might invest in IWM to add diversification and to tap into the growth potential of smaller, more entrepreneurial companies. A key risk is that small-cap stocks can be more volatile, so the ETF’s price can move up and down more than the overall market.
How much will it cost me?The iShares Russell 2000 ETF (IWM) has an expense ratio of 0.19%, which means you’ll pay $1.90 per year for every $1,000 invested. This cost is slightly higher than average for passively managed ETFs because it tracks a more specialized index of small-cap stocks, which can involve higher management and operational costs.
What would affect this ETF?The iShares Russell 2000 ETF (IWM), which focuses on U.S. small-cap companies, could benefit from economic growth and innovation in sectors like technology and healthcare, as these industries often drive entrepreneurial success. However, it may face challenges from rising interest rates, which can increase borrowing costs for smaller companies, and economic slowdowns that disproportionately impact small-cap stocks. Regulatory changes or sector-specific disruptions could also influence the ETF's performance.

IWM Top 10 Holdings

IWM’s story right now is being written largely by its health care and tech names, with BrightSpring, Alkermes, and Glaukos all rising and giving the fund a helpful lift. ViaSat has also been climbing, adding some punch from the technology side. On the flip side, Hut 8 has been lagging lately, and Moog and Cytokinetics have shown more mixed, stop‑and‑go action that can dampen momentum. Overall, the ETF is broadly spread across U.S. small caps, but with a noticeable tilt toward health care and financials rather than mega-cap tech giants.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Hut 80.37%$293.92M$12.12B453.11%
Moog0.36%$287.61M$12.39B101.89%
73
Outperform
UMB Financial0.35%$278.58M$11.07B33.01%
77
Outperform
ViaSat0.33%$261.64M$10.60B300.84%
56
Neutral
Cytokinetics0.32%$255.67M$9.60B108.99%
57
Neutral
BrightSpring Health Services, Inc.0.31%$250.63M$11.72B212.32%
67
Neutral
Glaukos0.31%$249.34M$9.83B95.28%
61
Neutral
Brinker International0.31%$247.84M$9.17B40.31%
70
Neutral
Old National Bancorp Capital0.30%$241.63M$10.19B29.27%
80
Outperform
CareTrust REIT0.30%$237.36M$9.91B25.29%
80
Outperform

IWM Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
293.47
Positive
100DMA
280.15
Positive
200DMA
266.01
Positive
Market Momentum
MACD
1.15
Negative
RSI
55.64
Neutral
STOCH
80.72
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IWM, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 294.49, equal to the 50-day MA of 293.47, and equal to the 200-day MA of 266.01, indicating a bullish trend. The MACD of 1.15 indicates Negative momentum. The RSI at 55.64 is Neutral, neither overbought nor oversold. The STOCH value of 80.72 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IWM.

IWM Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$81.49B0.19%
62
Neutral
$109.69B0.06%
65
Neutral
$79.92B0.03%
66
Neutral
$22.33B0.03%
64
Neutral
$16.91B0.06%
62
Neutral
$288.36M0.75%
66
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IWM
iShares Russell 2000 ETF
298.25
80.20
36.78%
IJR
iShares Core S&P Small Cap ETF
VB
Vanguard Small-Cap ETF
SCHA
Schwab U.S. Small-Cap ETF
VTWO
Vanguard Russell 2000 ETF
GSC
Goldman Sachs Small Cap Core Equity ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement